ArticleBMC women's health2025
An objective test to assess upper limb functionality in patients with breast cancer-related lymphedema: investigation of the psychometric properties of the upper limb functional test (ULIFT).
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough upper limb (UL) functionality was reported to be adversely affected in patients with breast cancer- related lymphedema (BCRL), there is currently no validated, objective performance-based assessment tool designed to evaluate UL function in this population. The Upper Limb Functional Test (ULIFT) was adapted from the ADL test (TGlittre), which is widely used in clinical settings and research, and was developed to assess unilateral UL functionality. Therefore, the present study aimed to evaluate the psychometric properties of the ULIFT in patients with BCRL.
methodsThe study involved 36 women with unilateral BCRL and 30 healthy women controls. Intraclass correlation coefficients (ICC) were used to assess test-retest reliability. ULIFT was conducted a second time with 36 patients (100% of the total sample) over a period of 7 to 14 days for test-retest reliability analysis. The following measures were used to investigate ULIFT convergent validity: Range of motion was assessed using a universal goniometer; UL disability with the Disability of the Arm, Shoulder and Hand (DASH) questionnaire; hand grip strength with a Jamar dynamometer; and quality of life (QoL) with the Short Form 36-item Health Survey (SF-36) survey, and Upper Limb Lymphedema 27 (ULL-27). The receiver operating characteristic (ROC) curve analysis was conducted as part of the known-group validity assessment to establish a cut-off point for ULIFT in distinguishing between patients with BCRL and healthy controls.
resultsThe ULIFT showed excellent test-retest reliability [ICC [95%] 0.92 (0.86-0.96)], a standard error of measurement of 3.91 s, and a minimum detectable change of 10.83 s. The sensitivity of 72.2%, specificity of 73.3% and AUC of 0.773 indicate a moderate ability of ULIFT to discriminate patients with and without impairment at a cut-off of 110.125 s. Significant correlations were found between ULIFT and UL functional measures (r ≥ 0.3), indicating convergent validity.
conclusionULIFT is a reliable and valid objective measurement tool for assessing unilateral UL function. The cut-off time of 110.125 s may help in clinical decision-making, particularly when used in conjunction with other assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.